| scholarly article | Q13442814 |
| P356 | DOI | 10.1083/JCB.121.3.679 |
| P953 | full work available at URL | https://rupress.org/jcb/article-pdf/121/3/679/1256517/679.pdf |
| https://europepmc.org/articles/PMC2119570 | ||
| https://europepmc.org/articles/PMC2119570?pdf=render | ||
| https://rupress.org/jcb/article-pdf/121/3/679/1474008/679.pdf | ||
| P932 | PMC publication ID | 2119570 |
| P698 | PubMed publication ID | 7683690 |
| P5875 | ResearchGate publication ID | 277465785 |
| P2093 | author name string | D. R. Clemmons | |
| J. I. Jones | |||
| C. Camacho-Hubner | |||
| W. H. Busby | |||
| A. Gockerman | |||
| P2860 | cites work | Novel regulators of bone formation: molecular clones and activities | Q24297338 |
| Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's | Q24339580 | ||
| Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta | Q24679265 | ||
| Recent developments in the cell biology of basic fibroblast growth factor | Q24679568 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 | Q28279735 | ||
| Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions | Q28285933 | ||
| Negative regulation of transforming growth factor-beta by the proteoglycan decorin | Q28292224 | ||
| Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation | Q28296150 | ||
| Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor | Q29616189 | ||
| Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor | Q33784803 | ||
| The proto-oncogene int-1 encodes a secreted protein associated with the extracellular matrix | Q33919776 | ||
| Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I. | Q34578087 | ||
| Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix | Q34613112 | ||
| An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. | Q34623199 | ||
| Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells | Q35580262 | ||
| A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane | Q35818217 | ||
| Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells | Q36219208 | ||
| Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation | Q36219245 | ||
| A dual receptor system is required for basic fibroblast growth factor activity | Q36428185 | ||
| Cytokines in context | Q36529819 | ||
| Insulin-like growth factor binding proteins: roles in regulating IGF physiology | Q36670514 | ||
| Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I | Q37583391 | ||
| Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules | Q38345199 | ||
| Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF I-induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis? | Q41668778 | ||
| High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor | Q41687095 | ||
| Three Distinct Forms of Insulin-Like Growth Factor Binding Proteins are Released by Decidual Cells in Culture* | Q42465706 | ||
| Solution structure of human plasma fibronectin as a function of NaCl concentration determined by small-angle X-ray scattering | Q42646692 | ||
| Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. | Q51623886 | ||
| Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin | Q52162407 | ||
| Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1 | Q53985452 | ||
| Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis | Q59067534 | ||
| Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins | Q67695232 | ||
| Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion | Q67897224 | ||
| Identification of somatomedin/insulin-like growth factor immunoreactive cells in the human fetus | Q68191125 | ||
| Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II | Q68431796 | ||
| Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies | Q68962393 | ||
| Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus | Q68975709 | ||
| Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene | Q69344366 | ||
| Immunological distribution of one form of insulin-like growth factor (IGF)-binding protein and IGF peptides in human fetal tissues | Q69354523 | ||
| Proteoglycans in cell regulation | Q69522593 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | extracellular matrix | Q193825 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 679-687 | |
| P577 | publication date | 1993-05-01 | |
| P1433 | published in | Journal of Cell Biology | Q1524550 |
| P1476 | title | Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I | |
| P478 | volume | 121 |
| Q71434072 | 1 alpha,25-dihydroxyvitamin D3 increases IGF binding protein-5 expression in cultured osteoblasts |
| Q93089571 | A High-Throughput Workflow to Study Remodeling of Extracellular Matrix-Based Microtissues |
| Q64925304 | A systems perspective of heterocellular signaling. |
| Q38624157 | Advanced Strategies for Articular Cartilage Defect Repair |
| Q36826856 | Age-related macular degeneration-associated silent polymorphisms in HtrA1 impair its ability to antagonize insulin-like growth factor 1. |
| Q71965133 | Altered IGFBP5 gene expression in the cerebellar external germinal layer of weaver mutant mice |
| Q40838442 | Antiproliferative effects of insulin-like growth factor-binding protein-3 in mesenchymal chondrogenic cell line RCJ3.1C5.18. relationship to differentiation stage |
| Q41450482 | Apoptosis, tumour invasion and prostate cancer |
| Q42455214 | Axon initiation and growth cone turning on bound protein gradients. |
| Q34667976 | B-cell lymphopoiesis is regulated by cathepsin L. |
| Q36793323 | Basal lamina and other extracellular matrix produced by bovine granulosa cells in anchorage-independent culture |
| Q47912563 | Binding of IGF-I to preimplantation rabbit embryos and their coats |
| Q36904666 | Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I |
| Q37388231 | Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts |
| Q42413507 | Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model. |
| Q26751449 | Cell surface receptors for CCN proteins |
| Q33607372 | Cellular actions of insulin-like growth factor binding proteins |
| Q33644573 | Characteristics of skeletal muscle in mdx mutant mice |
| Q62267736 | Characterization of insulin-like growth factor binding proteins and regulation of IGFBP3 in human mesangial cells |
| Q37409389 | Characterization of valvular interstitial cell function in three dimensional matrix metalloproteinase degradable PEG hydrogels |
| Q35731942 | Complement 1s is the serine protease that cleaves IGFBP-5 in human osteoarthritic joint fluid. |
| Q47161268 | Computer simulation models as a tool to investigate the role of microRNAs in osteoarthritis |
| Q44440538 | Control of Insulin-Like Growth Factor Binding Protein-5 Protease Synthesis and Secretion by Human Fibroblasts and Porcine Aortic Smooth Muscle Cells |
| Q64463826 | Control of mammary involution by insulin-like growth factor binding proteins: role of prolactin |
| Q49108791 | Coordinate IGF-I and IGFBP5 gene expression in perinatal rat brain after hypoxia-ischemia |
| Q38359116 | Cortisol inhibits the synthesis of insulin-like growth factor-binding protein-5 in bone cell cultures by transcriptional mechanisms |
| Q42490470 | Cultured incisors display major modifications in basal lamina deposition without further effect on odontoblast differentiation |
| Q38968053 | Customized biomaterials to augment chondrocyte gene therapy |
| Q74308159 | Cyclic AMP agonists increase levels of insulin-like growth factor (IGF) binding protein-6 in PC12 rat phaeochromocytoma cells |
| Q42491727 | Damage control mechanisms in articular cartilage: the role of the insulin-like growth factor I axis |
| Q34367785 | Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5. |
| Q33847396 | Development and postnatal regulation of adult myoblasts |
| Q46266168 | Development of embryonic chick insulin cells in culture: beneficial effects of serum-free medium, raised nutrients, and biomatrix |
| Q47921690 | Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells |
| Q38299912 | Diminished expression of insulin-like growth factor (IGF) binding protein-5 and activation of IGF-I-mediated autocrine growth in simian virus 40-transformed human fibroblasts |
| Q37418923 | Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions |
| Q35971304 | Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy |
| Q36459287 | E-peptides control bioavailability of IGF-1. |
| Q59336634 | Effect of diets supplemented with linseed alone or combined with vitamin E and selenium or with plant extracts, on transcriptome in growing-finishing Italian Large White pigs |
| Q36964578 | Effects of insulin-like growth factor binding proteins in bone -- a matter of cell and site |
| Q36714137 | Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model |
| Q41440987 | Enhanced expression of dihydrofolate reductase by bovine kidney epithelial cells results in altered cell morphology, IGF‐I responsiveness, and IGF binding protein‐3 expression |
| Q33964969 | Epigenetic signals during odontoblast differentiation |
| Q33866151 | Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer. |
| Q36001447 | Evidence that IGF-binding protein-5 functions as a growth factor |
| Q30384833 | Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer. |
| Q42457781 | Expression and localization of insulin-like growth factor-1 in normal and post-burn hypertrophic scar tissue in human |
| Q71956626 | Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens |
| Q48543210 | Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness |
| Q51131202 | Expression of insulin-like growth factor and binding protein genes during nephrogenesis. |
| Q38340992 | Expression of insulin-like growth factor-binding protein messenger RNAs in developing rat oligodendrocytes and astrocytes |
| Q33744976 | Extracellular matrix remodelling and cellular differentiation |
| Q35216162 | Fibrotic response in fibroblasts from congenital disorders of glycosylation |
| Q52192373 | Gene expression of the insulin-like growth factor system during mouse kidney development. |
| Q28215493 | Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis |
| Q41693134 | General aspects of insulin-like growth factor binding proteins |
| Q33975045 | Genetics, chemistry, and function of the IGF/IGFBP system |
| Q42727595 | Glucose Regulation of Thrombospondin and Its Role in the Modulation of Smooth Muscle Cell Proliferation |
| Q77360084 | Glycosaminoglycan-promoted muscle reinnervation and insulin-like growth factor-I levels are affected by anti-growth hormone-releasing hormone exposure |
| Q60649902 | Glycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: blockade of motor neuron death in the wobbler mouse |
| Q73561752 | Glycosaminoglycans treatment increases IGF-I muscle levels and counteracts motor neuron death: A novel nonanticoagulant action |
| Q37147591 | Growth hormone, insulin-like growth factors, and the skeleton |
| Q36235477 | High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells--implications for the modulation of FGF-2. |
| Q54334425 | High force development augments skeletal muscle signalling in resistance exercise modes equalized for time under tension. |
| Q41508533 | Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy |
| Q34982361 | IGF binding protein-4 is required for the growth effects of glucagon-like peptide-2 in murine intestine |
| Q37334106 | IGF binding proteins (IGFBPs) and regulation of breast cancer biology. |
| Q40490283 | IGF binding proteins and their functions |
| Q73793423 | IGF-1 stimulates synthesis of undersulfated proteoglycans and of hyaluronic acid by peritubular cells from immature rat testis |
| Q40710505 | IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts |
| Q40948182 | IGF-I and retinoic acid regulate the distribution pattern of IGFBPs synthesized by the canine mammary tumor cell line CMT-U335. |
| Q44833653 | IGF-I increases IGFBP-5 and collagen alpha1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells |
| Q35836632 | IGFBP ratio confers resistance to IGF targeting and correlates with increased invasion and poor outcome in breast tumors |
| Q34740473 | IGFBP-4 and -5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells |
| Q35672107 | IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF. |
| Q40727399 | Immunohistochemical pattern of insulin-like growth factor (IGF) I, IGF II and IGF binding proteins 1 to 6 in carcinoma in situ of the testis |
| Q34030616 | In vitro studies of insulin-like growth factor I and bone |
| Q36095787 | Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism |
| Q40923668 | Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line |
| Q43937867 | Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis |
| Q38574758 | Inhibition of proliferation in 8-week-old mdx mouse muscle fibroblasts in vitro |
| Q90479283 | Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease |
| Q64966018 | Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases. |
| Q24316404 | Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit |
| Q53557500 | Insulin-like growth factor binding protein (IGFBP)-mediated hair cell survival on the mouse utricle exposed to neomycin: the roles of IGFBP-4 and IGFBP-5. |
| Q31807473 | Insulin-like growth factor binding protein 5 and type-1 insulin-like growth factor receptor are differentially regulated during apoptosis in cerebellar granule cells |
| Q35114599 | Insulin-like growth factor binding protein proteolysis |
| Q24294434 | Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions |
| Q36236830 | Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism |
| Q35083605 | Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition |
| Q41489957 | Insulin-like growth factor binding proteins and their role in controlling IGF actions |
| Q33904097 | Insulin-like growth factor binding proteins: IGF-dependent and -independent effects in the mammary gland |
| Q30417447 | Insulin-like growth factor binding proteins: a structural perspective |
| Q41058586 | Insulin-like growth factor receptors and binding proteins |
| Q37382009 | Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults |
| Q38361431 | Insulin-like growth factor-I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells |
| Q36417183 | Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis |
| Q37733826 | Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation |
| Q41056187 | Insulin-like growth factors and inflammatory bowel disease |
| Q24800144 | Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function |
| Q34767957 | Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth |
| Q38317027 | Interactions between bcl-2 and the IGF system control apoptosis in the developing mouse brain |
| Q46769458 | Interleukin-11 inhibits expression of insulin-like growth factor binding protein-5 mRNA in decidualizing human endometrial stromal cells |
| Q36163374 | Investigating endogenous peptides and peptidases using peptidomics |
| Q37695701 | Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor |
| Q42436682 | Localization of insulin-like growth factor binding protein-2 in chondrocytes of bovine articular cartilage |
| Q60169586 | Localization of mRNAs for insulin-like growth factor binding proteins 1 to 6 in rat kidney |
| Q40159420 | Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix. |
| Q28618638 | Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures |
| Q34195881 | Matrix production and remodeling as therapeutic targets for uterine leiomyoma |
| Q38293068 | Mechanical regulation of IGF-I and IGF-binding protein gene transcription in bladder smooth muscle cells |
| Q39689738 | Mechanistic investigations into interactions between IGF-I and IGFBPs and their impact on facilitating cell migration on vitronectin. |
| Q42799469 | Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-induced insulin-like growth factor-I receptor signaling in ishikawa endometrial cancer cells |
| Q38328312 | MiRNA-140 is a negative feedback regulator of MMP-13 in IL-1β-stimulated human articular chondrocyte C28/I2 cells |
| Q37257924 | Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults |
| Q38128702 | Molecular mechanisms of the cartilage-specific microRNA-140 in osteoarthritis. |
| Q36955081 | Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer |
| Q28566855 | Muscle reinnervation and IGF-I synthesis are affected by exposure to heparin: an effect partially antagonized by anti-growth hormone-releasing hormone |
| Q42450805 | Muscle reinnervation following neonatal nerve crush. Interactive effects of glycosaminoglycans and insulin-like growth factor-I. |
| Q44068358 | Mutation of the RGD sequence does not affect plasma membrane association and growth inhibitory effects of elevated IGFBP-2 in vivo |
| Q38647615 | NFAT3 and TGF-β/SMAD3 regulate the expression of miR-140 in osteoarthritis |
| Q73443629 | NMR 15N relaxation of the insulin-like growth factor (IGF)-binding domain of IGF binding protein-5 (IGFBP-5) determined free in solution and in complex with IGF-II |
| Q50086407 | Nephrotoxicity Induced by Cisplatin Intake in Experimental Rats and Therapeutic Approach of Using Mesenchymal Stem Cells and Spironolactone |
| Q46842475 | Neural and head induction by insulin-like growth factor signals |
| Q58788300 | Neurite Growth and Polarization on Vitronectin Substrate after in Vitro Trauma is not Enhanced after IGF Treatment |
| Q37254131 | Nuclear factor I transcription factors regulate IGF binding protein 5 gene transcription in human osteoblasts |
| Q28616606 | O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis |
| Q35755050 | Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal Phenotypes |
| Q52127494 | Partial purification and characterization of proteins with growth promoting activities from ovine mammary gland secretions. |
| Q47331410 | Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts |
| Q44483053 | Production of insulin-like growth factor binding-proteins by bovine adrenomedullary cells: differential regulation by IGF-I and dexamethasone |
| Q37375061 | Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture. |
| Q34362776 | Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland |
| Q42739074 | Quantitative characterization of binding of small molecules to extracellular matrix |
| Q33184835 | Regulation of IGFBP-5 expression during tumourigenesis and differentiation of oral keratinocytes |
| Q77608195 | Regulation of insulin-like growth factors I and II and their binding proteins in human bone marrow stromal cells by dexamethasone |
| Q30931885 | Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes |
| Q81065549 | Regulatory Actions of Insulin-like Growth Factor-binding Proteins |
| Q44660487 | Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts |
| Q37322147 | Role of insulin-like growth factor binding proteins in mammary gland development |
| Q33853206 | Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis |
| Q36234276 | Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4. |
| Q36782493 | Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress |
| Q36111179 | Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions |
| Q28069429 | Roles of microRNA and signaling pathway in osteoarthritis pathogenesis |
| Q37123969 | Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism |
| Q41250241 | Serum factors inhibit melanoma cell surface expression of type I and type II IGF receptors |
| Q38295651 | Skeletal growth factors regulate the synthesis of insulin-like growth factor binding protein-5 in bone cell cultures |
| Q47875941 | Spaceflight modulates insulin-like growth factor binding proteins and glucocorticoid receptor in osteoblasts |
| Q24533385 | Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions |
| Q22253898 | Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions |
| Q36233928 | Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression |
| Q88936916 | The Physical and Biochemical Properties of the Extracellular Matrix Regulate Cell Fate |
| Q92842183 | The Role of Gene Therapy in Cartilage Repair |
| Q90267521 | The Role of the IGF-1 Signaling Cascade in Muscle Protein Synthesis and Anabolic Resistance in Aging Skeletal Muscle |
| Q36940050 | The extracellular matrix in multiple sclerosis pathology |
| Q38327469 | The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells |
| Q42066582 | The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration |
| Q41175229 | The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action |
| Q40835429 | Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1's ability to inhibit insulin-like growth factor-I-stimulated protein synthesis |
| Q24310632 | Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression |
| Q33608667 | Transcriptional regulation of the IGF signaling pathway by amino acids and insulin-like growth factors during myogenesis in Atlantic salmon |
| Q47685883 | Use of differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes |
Search more.